Run Pharmaceuticals Private Limited
About Run Pharmaceuticals Private Limited
Data last updated:
Run Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015PTC270681. Its GSTIN is 27AAHCR5548L1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satyaprakash Baijnath Gupta and Mo Hasan Mo Sharif Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101 2nd Floor Tulif Building, Flower Valley Khadak Pada Kalyan West, Maharashtra, India – 421301.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.61 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹891 (net margin -0.1%) and EBITDA of -₹651 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Run Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address101 2nd Floor Tulif Building, Flower Valley Khadak Pada Kalyan West, Maharashtra, India – 421301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Run Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Run Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Run Pharmaceuticals Private Limited, buy the company report.
Financials of Run Pharmaceuticals Private Limited
FY 2025 filings availableRun Pharmaceuticals Private Limited reported revenue of ₹8.61 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 10% fall in the latest year. EBITDA fell 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹651 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹891 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Run Pharmaceuticals Private Limited, buy the company report.
Board of directors of Run Pharmaceuticals Private Limited
Run Pharmaceuticals has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyaprakash Baijnath Gupta | Director | 18 Sep 2025 | 1 Years 1 Months | Current |
| Mo Hasan Mo Sharif Khan | Director | 17 Nov 2025 | 0 Years 11 Months | Current |
Shareholding
The shareholding of Run Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Run Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Run Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Run Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Run Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR5548L1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Run Pharmaceuticals Private Limited, buy the company report.
Recent activity
Run Pharmaceuticals Private Limited has 13 board changes on record since 2015: 8 appointments and 5 cessations. The latest: Mo Hasan Mo Sharif Khan was appointed as Director on 17 Nov 2025.
4 earlier events are in the company report.
Frequently asked questions
Run Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 December 2015 (11+ years old) and is registered under CIN U74120MH2015PTC270681.
Run Pharmaceuticals has 2 current directors:
- Satyaprakash Baijnath Gupta - Director
- Mo Hasan Mo Sharif Khan - Director
The latest financial statements of Run Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Run Pharmaceuticals is 27AAHCR5548L1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Run Pharmaceuticals is U74120MH2015PTC270681. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Run Pharmaceuticals was incorporated on 03 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Mo Hasan Mo Sharif Khan was appointed as Director on 17 Nov 2025. Satyaprakash Baijnath Gupta was appointed as Director on 18 Sep 2025. Rahul Ramesh Patil was appointed as Director on 02 Sep 2025. Run Pharmaceuticals has 13 board changes on record in total.
The registered office of Run Pharmaceuticals is at 101 2nd Floor Tulif Building, Flower Valley Khadak Pada Kalyan West, Maharashtra, India – 421301.
Run Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Run Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.